secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001213900-24-041708
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NKGen Biotech raises $1M gross from convertible notes; warrants at $2.00
------------------------------------------------------------------------

- Total gross proceeds of $1M from three convertible promissory notes to Meteora ($200k), Alpha ($500k), and AJB ($300k).
- Aggregate principal amount $1.21M; notes mature in 12 months; convertible at $2.00 per share.
- Warrants issued to purchase up to 1.1M shares at $2.00 per share for five years.
- Alpha and AJB have options to require additional notes and warrants worth up to $2.96M and 2.64M shares.
- Notes include original issue discounts; Meteora Note bears 12% interest; others zero coupon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024041708/0001213900-24-041708-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024041708/ea0205751-8k_nkgenbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-041708

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer